Results
1 -
10 of
107
(Click
here to explore results)
- Quantitative analysis of biochemical processes in living cells at a single-molecule level: a case of olaparib–PARP1 (DNA repair protein) interactions. Aneta Karpińska, Marta Pilz, Joanna Buczkowska, Paweł J. Żuk, Karolina Kucharska, Gaweł Magiera, Karina Kwapiszewska, Robert Hołyst
, Analyst
, 2021
, 146
, 7131
- Hypoxia-activated prodrugs of phenolic olaparib analogues for tumour-selective chemosensitisation. Way W. Wong, Sophia F. O'Brien-Gortner, Robert F. Anderson, William R. Wilson, Michael P. Hay, Benjamin D. Dickson
, RSC Med. Chem.
, 2023
, 14
, 1309
- Nanoparticle delivery of chemosensitizers improve chemotherapy efficacy without incurring additional toxicity. Joseph M. Caster, Manish Sethi, Sonya Kowalczyk, Edina Wang, Xi Tian, Sayed Nabeel Hyder, Kyle T. Wagner, Ying-Ao Zhang, Chintan Kapadia, Kin Man Au, Andrew Z. Wang
, Nanoscale
, 2015
, 7
, 2805
- An efficient synthetic route to l-γ-methyleneglutamine and its amide derivatives, and their selective anticancer activity. Md Imran Hossain, Ajit G. Thomas, Fakhri Mahdi, Amna T. Adam, Nicholas S. Akins, Morgan M. Woodard, Jason J. Paris, Barbara S. Slusher, Hoang V. Le
, RSC Adv.
, 2021
, 11
, 7115
- A scalable and eco-friendly total synthesis of poly(ADP-ribose) polymerase inhibitor Olaparib. Indranil Chatterjee, Deblina Roy, Gautam Panda
, Green Chem.
, 2023
, 25
, 9097
- Red Si–rhodamine drug conjugates enable imaging in GFP cells. Eunha Kim, Katherine S. Yang, Randy J. Giedt, Ralph Weissleder
, Chem. Commun.
, 2014
, 50
, 4504
- Novel PARP inhibitors sensitize human leukemic cells in an endogenous PARP activity dependent manner. Mahesh Hegde, Kempegowda Mantelingu, Hassan A. Swarup, Chottanahalli S. Pavankumar, Imteyaz Qamar, Sathees C. Raghavan, Kanchugarakoppal S. Rangappa
, RSC Adv.
, 2016
, 6
, 6308
- Scalable 18F processing conditions for copper-mediated radiofluorination chemistry facilitate DoE optimization studies and afford an improved synthesis of [18F]olaparib. Gregory D. Bowden, Nantanat Chailanggar, Bernd J. Pichler, Andreas Maurer
, Org. Biomol. Chem.
, 2021
, 19
, 6995
- Free drug and ROS-responsive nanoparticle delivery of synergistic doxorubicin and olaparib combinations to triple negative breast cancer models. Robert J. Cavanagh, Patrícia F. Monteiro, Cara Moloney, Alessandra Travanut, Fatemeh Mehradnia, Vincenzo Taresco, Ruman Rahman, Stewart G. Martin, Anna M. Grabowska, Marianne B. Ashford, Cameron Alexander
, Biomater. Sci.
, 2024
, 12
, 1822
- Design, synthesis and in silico studies of new quinazolinone derivatives as antitumor PARP-1 inhibitors. Sayed K. Ramadan, Eman Z. Elrazaz, Khaled A. M. Abouzid, Abeer M. El-Naggar
, RSC Adv.
, 2020
, 10
, 29475